Cabot (CBT) Scheduled to Post Quarterly Earnings on Monday

Cabot (NYSE:CBT) will be announcing its earnings results after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $1.47 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.42 earnings per share for the quarter, missing analysts’ consensus estimates of $1.56 by ($0.14). The company had revenue of $968.00 million during the quarter, compared to analyst estimates of $1.09 billion. Cabot had a net margin of 7.48% and a return on equity of 25.98%. The business’s revenue for the quarter was down 15.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.73 EPS. On average, analysts expect Cabot to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Cabot Stock Performance

Shares of Cabot stock opened at $65.66 on Monday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.17 and a quick ratio of 1.37. The firm has a market cap of $3.67 billion, a P/E ratio of 12.41, a P/E/G ratio of 2.12 and a beta of 1.29. The firm has a 50 day simple moving average of $69.25 and a 200 day simple moving average of $69.84. Cabot has a fifty-two week low of $63.73 and a fifty-two week high of $83.74.

Analyst Ratings Changes

A number of analysts recently weighed in on CBT shares. StockNews.com started coverage on shares of Cabot in a report on Thursday, October 5th. They issued a “buy” rating for the company. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Friday, August 11th. Finally, Credit Suisse Group lowered their target price on shares of Cabot from $85.00 to $82.00 and set an “outperform” rating for the company in a report on Tuesday, August 8th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.75.

Hedge Funds Weigh In On Cabot

Hedge funds and other institutional investors have recently made changes to their positions in the company. Virtu Financial LLC bought a new position in shares of Cabot during the fourth quarter worth $258,000. Engineers Gate Manager LP bought a new stake in Cabot in the 1st quarter valued at $255,000. Snowden Capital Advisors LLC lifted its position in Cabot by 5.6% in the 1st quarter. Snowden Capital Advisors LLC now owns 3,323 shares of the specialty chemicals company’s stock valued at $255,000 after acquiring an additional 176 shares in the last quarter. Cullen Capital Management LLC bought a new stake in Cabot in the 1st quarter valued at $239,000. Finally, Creative Planning bought a new stake in Cabot in the 2nd quarter valued at $236,000. 91.05% of the stock is owned by institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.